NovoCure (NVCR) EBT Growth (3y) (2017 - 2026)
NovoCure (NVCR) EBT Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | -2.34% |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 20.27% |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 5.75% |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 35.51% |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 23.63% |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 25.85% |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 6.73% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 89.20% |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 17.92% |
| 10 | NovoCure | 2.06 Bn | 1.62 Bn | 142.48 Mn | 38.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 38.64% |
| Mar 31, 2026 | -10.68% |
| Dec 31, 2025 | -7.95% |
| Sep 30, 2025 | -8.63% |
| Jun 30, 2025 | -14.41% |
| Mar 31, 2025 | -129.23% |
| Dec 31, 2024 | -29.24% |
| Sep 30, 2024 | -27.02% |
| Jun 30, 2024 | -19.75% |
| Mar 31, 2024 | -126.20% |
| Dec 31, 2023 | -85.34% |
| Sep 30, 2023 | -85.36% |
| Jun 30, 2023 | -148.29% |
| Mar 31, 2023 | -106.36% |
| Dec 31, 2022 | -173.47% |
| Sep 30, 2022 | -171.50% |
| Jun 30, 2022 | -715.91% |
| Mar 31, 2022 | 33.34% |
| Dec 31, 2021 | -33.19% |
| Sep 30, 2021 | -11.28% |